Hollander v. RANBAXY LABORATORIES INC.

MEMORANDUM REGARDING CONSTITUTIONALITY OF 35 U.S.C. § 292(b)

BAYLSON, District Judge.

I. Introduction

Plaintiff Bentley A. Hollander (“Hollander”) initiated this qui tam action against Defendant Ranbaxy Laboratories, Inc. (“Ranbaxy”) for alleged violations of the False Marking Statute, 35 U.S.C. § 292. Section 292 penalizes the marking of products with false or expired patent numbers and allows “[a]ny person” to sue for the statutory penalty. See § 292(a), (b). The Court previously denied Ranbaxy’s Motion to Dismiss for failure to state a claim and Hollander’s Cross-Motion for Judgment on the…